Skip to main content
. 2020 Aug 19;21:204. doi: 10.1186/s13059-020-02118-9

Fig. 3.

Fig. 3

Applications of CRISPR and transposon mutagenesis for in vivo cancer screens. Cancer is typically genetically and phenotypically heterogeneous, and immune cells in the microenvironment play a pivotal role in oncogenesis. Key areas for investigation of cancer by in vivo screens include genetic mechanisms of tumor heterogeneity, metastasis, immune evasion, and resistance to treatment. “T” = transposon mutagenesis; “C” = CRISPR